Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Immunohistochemical expression of PD-L1 in early and late stage non-small cell lung cancer: Correlation with clinicopathological and molecular features.

Kokkotou E, Rapti V, Grapsa D, Bakakos P, Papadopoulos S, Bobos M, Iliadis K, Syrigos K.

Ann Oncol. 2019 Apr;30 Suppl 2:ii5. doi: 10.1093/annonc/mdz072.016. No abstract available.

2.

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?

Tsilogianni Z, Baker JR, Papaporfyriou A, Papaioannou AI, Papathanasiou E, Koulouris NG, Daly L, Ito K, Hillas G, Papiris S, Bakakos P, Loukides S.

J Clin Med. 2020 Feb 9;9(2). pii: E473. doi: 10.3390/jcm9020473.

3.

Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.

Karampitsakos T, Hillas G, Zervas E, Bakakos P, Stratakos G, Dimakou K, Manali E, Bouros D, Papiris S, Tzouvelekis A; PAIR study investigators.

Pulm Pharmacol Ther. 2020 Feb;60:101882. doi: 10.1016/j.pupt.2019.101882. Epub 2019 Dec 24.

PMID:
31881275
4.

New paradigm in asthma management: switching between biologics!

Mukherjee M, Bakakos P, Loukides S.

Allergy. 2019 Sep 8. doi: 10.1111/all.14038. [Epub ahead of print]

PMID:
31494955
5.

Severe Eosinophilic Asthma.

Bakakos A, Loukides S, Bakakos P.

J Clin Med. 2019 Sep 2;8(9). pii: E1375. doi: 10.3390/jcm8091375. Review.

6.

Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

Papathanasiou E, Bakakos P, Hillas G, Ntontsi P, Blizou M, Kostikas K, Koulouris N, Papiris S, Loukides S.

J Allergy Clin Immunol Pract. 2020 Jan;8(1):385-387.e2. doi: 10.1016/j.jaip.2019.05.052. Epub 2019 Jun 13. No abstract available.

PMID:
31257188
7.

Asthma-chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics.

Patentalakis G, Bakakos P, Papaporfyriou A, Papatheodorou G, Hillas G, Kostikas K, Papiris S, Koulouris N, Loukides S.

Allergy. 2019 Nov;74(11):2271-2273. doi: 10.1111/all.13865. Epub 2019 May 28. No abstract available.

PMID:
31077386
8.

The Economic Burden of Asthma in Greece: A Cross-Sectional Study.

Vellopoulou K, Bakakos P, Loukides S, Maniadakis N, Kourlaba G.

Appl Health Econ Health Policy. 2019 Oct;17(5):629-640. doi: 10.1007/s40258-019-00469-4.

PMID:
30997609
9.

Inflammatory profile in optimally treated patients with adult versus early-onset asthma.

Papaporfyriou A, Papaioannou AI, Hillas G, Konstantelou E, Tseliou E, Koulouris N, Papiris S, Bakakos P, Kostikas K, Loukides S.

Postgrad Med. 2019 Jun;131(5):324-329. doi: 10.1080/00325481.2019.1600884. Epub 2019 Apr 4.

PMID:
30920326
10.

Experimental and investigational phosphodiesterase inhibitors in development for asthma.

Ntontsi P, Detta A, Bakakos P, Loukides S, Hillas G.

Expert Opin Investig Drugs. 2019 Mar;28(3):261-266. doi: 10.1080/13543784.2019.1571582. Epub 2019 Jan 24. Review.

PMID:
30678501
11.

Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.

Papaioannou AI, Diamant Z, Bakakos P, Loukides S.

Respir Med. 2018 Sep;142:15-22. doi: 10.1016/j.rmed.2018.07.006. Epub 2018 Jul 17. Review.

PMID:
30170796
12.

Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People.

Tatsis N, Kakavas S, Metaxas E, Balis E, Tatsis G, Pantazis N, Bakakos P, Koulouris N, Hadjistavrou Κ.

Open Respir Med J. 2018 Jul 31;12:29-38. doi: 10.2174/1874306401812010029. eCollection 2018.

13.

Unraveling the Mysteries of the Asthmatic Airway Epithelium.

Loukides S, Bakakos P.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):9-10. doi: 10.1165/rcmb.2018-0040ED. No abstract available.

PMID:
29957048
14.

The self-reported prevalence and disease burden of asthma in Greece.

Kourlaba G, Bakakos P, Loukides S, Vellopoulou K, Solakidi A, Maniadakis N.

J Asthma. 2019 May;56(5):478-497. doi: 10.1080/02770903.2018.1471704. Epub 2018 Jun 22.

PMID:
29718784
15.

Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference?

Petta V, Loukides S, Kostikas K, Papaioannou AI, Papatheodorou G, Cholidou K, Tomos I, Papiris S, Koulouris NG, Bakakos P.

J Thorac Dis. 2018 Feb;10(2):740-748. doi: 10.21037/jtd.2018.01.45.

16.

An algorithmic approach for the treatment of severe uncontrolled asthma.

Zervas E, Samitas K, Papaioannou AI, Bakakos P, Loukides S, Gaga M.

ERJ Open Res. 2018 Mar 6;4(1). pii: 00125-2017. doi: 10.1183/23120541.00125-2017. eCollection 2018 Jan. Review.

17.

Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.

Papaioannou AI, Konstantelou E, Papaporfyriou A, Bartziokas K, Spathis A, Bakakos P, Loukides S, Koulouris N, Papiris S, Kostikas K.

Lung. 2018 Apr;196(2):201-205. doi: 10.1007/s00408-018-0099-5. Epub 2018 Feb 14.

PMID:
29445934
18.

Targeted anti-IL-13 therapies in asthma: current data and future perspectives.

Ntontsi P, Papathanassiou E, Loukides S, Bakakos P, Hillas G.

Expert Opin Investig Drugs. 2018 Feb;27(2):179-186. doi: 10.1080/13543784.2018.1427729. Epub 2018 Jan 19. Review.

PMID:
29334288
19.

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms.

Ntontsi P, Bakakos P, Papathanasiou E, Tsilogianni Z, Kostikas K, Hillas G, Papatheodorou G, Koulouris N, Papiris S, Loukides S.

J Breath Res. 2018 Feb 20;12(2):026013. doi: 10.1088/1752-7163/aa9d46.

PMID:
29176061
20.

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.

Papaioannou AI, Kostikas K, Papaporfyriou A, Angelakis L, Papathanasiou E, Hillas G, Mazioti A, Bakakos P, Koulouris N, Papiris S, Loukides S.

COPD. 2017 Dec;14(6):635-640. doi: 10.1080/15412555.2017.1386644. Epub 2017 Nov 3.

PMID:
29099646
21.

The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.

Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, Loukides S, Papiris S, Koulouris N, Bakakos P.

Cytokine. 2017 Nov;99:281-286. doi: 10.1016/j.cyto.2017.08.005. Epub 2017 Aug 31.

PMID:
28863927
22.

Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

Petta V, Perlikos F, Loukides S, Bakakos P, Chalkias A, Iacovidou N, Xanthos T, Tsekoura D, Hillas G.

Heart Fail Rev. 2017 Nov;22(6):753-763. doi: 10.1007/s10741-017-9646-z. Review.

PMID:
28840400
23.

Serum periostin in patients hospitalized for COPD exacerbations.

Konstantelou E, Papaioannou AI, Loukides S, Bartziokas K, Papaporfyriou A, Papatheodorou G, Bakakos P, Papiris S, Koulouris N, Kostikas K.

Cytokine. 2017 May;93:51-56. doi: 10.1016/j.cyto.2017.05.007. Epub 2017 May 13.

PMID:
28511944
24.

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach.

Souliotis K, Kousoulakou H, Hillas G, Bakakos P, Toumbis M, Loukides S, Vassilakopoulos T.

Front Public Health. 2017 Apr 5;5:67. doi: 10.3389/fpubh.2017.00067. eCollection 2017.

25.

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.

Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, Hillas G, Koulouris N, Papiris S, Papaioannou AI.

Allergy. 2017 Nov;72(11):1761-1767. doi: 10.1111/all.13184. Epub 2017 May 11.

PMID:
28407269
26.

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

Konstantellou E, Loukides S, Ntontsi P, Papathanasiou E, Kostikas K, Paptheodorou G, Hillas G, Papiris S, Koulouris NG, Bakakos P.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1129-1131.e3. doi: 10.1016/j.jaip.2017.03.005. Epub 2017 Apr 7. No abstract available.

PMID:
28396112
27.

Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients.

Theodorakopoulou EP, Gennimata SA, Harikiopoulou M, Kaltsakas G, Palamidas A, Koutsoukou A, Roussos C, Kosmas EN, Bakakos P, Koulouris NG.

Respir Physiol Neurobiol. 2017 Apr;238:47-54. doi: 10.1016/j.resp.2017.01.008. Epub 2017 Jan 18.

PMID:
28109942
28.

Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures.

Michaelides SA, Bablekos GD, Analitis A, Ionas G, Bakakos P, Charalabopoulos KA.

Postgrad Med J. 2017 Aug;93(1102):460-464. doi: 10.1136/postgradmedj-2016-134268. Epub 2017 Jan 5.

PMID:
28057838
29.

Severe asthma: anti-IgE or anti-IL-5?

Papathanassiou E, Loukides S, Bakakos P.

Eur Clin Respir J. 2016 Nov 7;3:31813. doi: 10.3402/ecrj.v3.31813. eCollection 2016. Review.

30.

Activin A and follistatin in patients with asthma. Does severity make the difference?

Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, Katafigiotis P, Koulouris NG, Papiris SA, Loukides S.

Respirology. 2017 Apr;22(3):473-479. doi: 10.1111/resp.12937. Epub 2016 Nov 2.

PMID:
27807906
31.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Nov;46(11):1498. doi: 10.1111/cea.12825. No abstract available.

PMID:
27790845
32.

Quantitative computed tomography: what does airway obstruction look-like?

Kallieri M, Papaioannou AI, Kostikas K, Bakakos P, Loukides S.

J Thorac Dis. 2016 Sep;8(9):E1044-E1046. No abstract available.

33.

Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.

Gianniou N, Katsaounou P, Dima E, Giannakopoulou CE, Kardara M, Saltagianni V, Trigidou R, Kokkini A, Bakakos P, Markozannes E, Litsiou E, Tsakatikas A, Papadopoulos C, Roussos C, Koulouris N, Rovina N.

Respir Med. 2016 Sep;118:7-14. doi: 10.1016/j.rmed.2016.07.006. Epub 2016 Jul 13.

34.

Predictors of future exacerbation risk in patients with asthma.

Papaioannou AI, Kostikas K, Bakakos P, Papaporfyriou A, Konstantellou E, Hillas G, Papatheodorou G, Koulouris NG, Papiris S, Loukides S.

Postgrad Med. 2016 Sep;128(7):687-92. doi: 10.1080/00325481.2016.1220807. Epub 2016 Aug 17.

PMID:
27494758
35.

Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.

Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P.

Respir Med. 2016 Jul;116:1-7. doi: 10.1016/j.rmed.2016.05.001. Epub 2016 May 3.

36.

Biomarkers Guided Treatment Strategies in Adult Patients with Asthma: Ready for the Clinical Field?

Tsilogianni Z, Ntontsi P, Papaioannou AI, Bakakos P, Loukides S.

Arch Immunol Ther Exp (Warsz). 2017 Feb;65(1):1-9. doi: 10.1007/s00005-016-0407-9. Epub 2016 Jun 8. Review.

PMID:
27271573
37.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Jul;46(7):923-31. doi: 10.1111/cea.12729. Epub 2016 May 3. Erratum in: Clin Exp Allergy. 2016 Nov;46(11):1498.

PMID:
26990030
38.

Fever and multilobular mass of the right lung in a young adult with asthma.

Sotiriou A, Koulouris N, Bakakos P.

Med Mycol Case Rep. 2015 Dec 5;10:7-10. doi: 10.1016/j.mmcr.2015.12.001. eCollection 2015 Dec.

39.

Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD.

Kavoura P, Kostikas K, Tselebis A, Bratis D, Kosmas E, Alchanatis M, Koulouris NG, Bakakos P, Loukides S.

J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):62-7. doi: 10.1097/HCR.0000000000000157.

PMID:
26629865
40.

Smoking asthma phenotype: diagnostic and management challenges.

Bakakos P, Kostikas K, Loukides S.

Curr Opin Pulm Med. 2016 Jan;22(1):53-8. doi: 10.1097/MCP.0000000000000221. Review.

PMID:
26606078
41.

Biomarkers in the Management of Chronic Lung Disease.

Kostikas K, Loukides S, Bakakos P.

Curr Top Med Chem. 2016;16(14):1537-8. No abstract available.

PMID:
26510585
42.

Vascular Biomarkers in Asthma and COPD.

Bakakos P, Patentalakis G, Papi A.

Curr Top Med Chem. 2016;16(14):1599-609. Review.

PMID:
26420364
43.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

Konstantellou E, Papaioannou AI, Loukides S, Patentalakis G, Papaporfyriou A, Hillas G, Papiris S, Koulouris N, Bakakos P, Kostikas K.

Respir Med. 2015 Nov;109(11):1404-9. doi: 10.1016/j.rmed.2015.09.009. Epub 2015 Sep 21.

44.

Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.

Rovina N, Dima E, Bakakos P, Tseliou E, Kontogianni K, Papiris S, Koutsoukou A, Koulouris NG, Loukides S.

Respir Med. 2015 May;109(5):580-7. doi: 10.1016/j.rmed.2015.03.002. Epub 2015 Mar 19.

45.

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma.

Emmanouil P, Loukides S, Kostikas K, Papatheodorou G, Papaporfyriou A, Hillas G, Vamvakaris I, Triggidou R, Katafigiotis P, Kokkini A, Papiris S, Koulouris N, Bakakos P.

Allergy. 2015 Jun;70(6):711-4. doi: 10.1111/all.12603. Epub 2015 Mar 18.

PMID:
25728058
46.

Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking.

Petta V, Bakakos P, Tseliou E, Kostikas K, Simoes DC, Konstantellou E, Hillas G, Koulouris NG, Papiris S, Loukides S.

Eur J Clin Invest. 2015 Jan;45(1):56-62. doi: 10.1111/eci.12379.

PMID:
25402718
47.

Increased levels of osteopontin in sputum supernatant in patients with COPD.

Papaporfyriou A, Loukides S, Kostikas K, Simoes DCM, Papatheodorou G, Konstantellou E, Hillas G, Papiris S, Koulouris N, Bakakos P.

Chest. 2014 Oct;146(4):951-958. doi: 10.1378/chest.13-2440.

PMID:
24902063
48.

Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.

Cholidou KG, Manali ED, Kapsimalis F, Kostakis ID, Vougas K, Simoes D, Markozannes E, Vogiatzis I, Bakakos P, Koulouris N, Alchanatis M.

Clin Res Cardiol. 2014 Oct;103(10):805-15. doi: 10.1007/s00392-014-0721-3. Epub 2014 May 13.

PMID:
24820928
49.

A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014.

Tsiodras S, Baka A, Mentis A, Iliopoulos D, Dedoukou X, Papamavrou G, Karadima S, Emmanouil M, Kossyvakis A, Spanakis N, Pavli A, Maltezou H, Karageorgou A, Spala G, Pitiriga V, Kosmas E, Tsiagklis S, Gkatzias S, Koulouris N, Koutsoukou A, Bakakos P, Markozanhs E, Dionellis G, Pontikis K, Rovina N, Kyriakopoulou M, Efstathiou P, Papadimitriou T, Kremastinou J, Tsakris A, Saroglou G.

Euro Surveill. 2014 Apr 24;19(16):20782. Erratum in: Euro Surveill. 2014;19(17):pii/20786.

50.

Serum angiopoietin-2 and CRP levels during COPD exacerbations.

Nikolakopoulou S, Hillas G, Perrea D, Tentolouris N, Loukides S, Kostikas K, Simoes D, Georgakopoulou E, Vogiatzakis E, Veldekis D, Bakakos P.

COPD. 2014 Feb;11(1):46-51. doi: 10.3109/15412555.2013.829436. Epub 2013 Oct 8.

PMID:
24102428

Supplemental Content

Loading ...
Support Center